Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Genotype-Phenotype Study of High-Resolution FMR1 Nucleic Acid and Protein Analyses in Fragile X Patients with Neurobehavioral Assessments
Dejan B. Budimirovic, Annette Schlageter, Stela Filipovic-Sadic, et al.
Brain Sciences (2020) Vol. 10, Iss. 10, pp. 694-694
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Applications of long-read sequencing to Mendelian genetics
Francesco Mastrorosa, Danny E. Miller, Evan E. Eichler
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 54
Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial
Elizabeth Berry‐Kravis, Mark Harnett, Scott A. Reines, et al.
Nature Medicine (2021) Vol. 27, Iss. 5, pp. 862-870
Closed Access | Times Cited: 102
Fragile X Syndrome: From Molecular Aspect to Clinical Treatment
Dragana Protić, Ramkumar Aishworiya, María Jimena Salcedo‐Arellano, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 1935-1935
Open Access | Times Cited: 60
A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)
Elizabeth Berry‐Kravis, Randi J. Hagerman, Dejan B. Budimirovic, et al.
Journal of Neurodevelopmental Disorders (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 47
Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment
Joseph Palumbo, Brian F. Thomas, Dejan B. Budimirovic, et al.
Journal of Neurodevelopmental Disorders (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 16
Sex differences in resting EEG power in Fragile X Syndrome
Elizabeth G. Smith, Ernest V. Pedapati, Rui Liu, et al.
Journal of Psychiatric Research (2021) Vol. 138, pp. 89-95
Open Access | Times Cited: 35
Sleep problems in fragile X syndrome: Cross‐sectional analysis of a large clinic‐based cohort
Dejan B. Budimirovic, Dragana Protić, Carol Delahunty, et al.
American Journal of Medical Genetics Part A (2021) Vol. 188, Iss. 4, pp. 1029-1039
Open Access | Times Cited: 34
Sex Differences in Brain Disorders
Małgorzata Ziemka‐Nałęcz, Paulina Pawelec, Karolina Ziąbska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14571-14571
Open Access | Times Cited: 15
A dual-mode targeted Nanopore sequencing assay for comprehensive SMN1 and SMN2 variant analysis
B. D. Hall, Sawsan Alyafei, Sathishkumar Ramaswamy, et al.
Journal of Molecular Diagnostics (2025)
Closed Access
Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis
Skylar Luu, Haley S. Province, Elizabeth Berry‐Kravis, et al.
Brain Sciences (2020) Vol. 10, Iss. 9, pp. 629-629
Open Access | Times Cited: 33
Optimization, validation and initial clinical implications of a Luminex-based immunoassay for the quantification of Fragile X Protein from dried blood spots
Anna E. Boggs, Lauren Schmitt, Richard D. McLane, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 19
Phenotypic variability to medication management: an update on fragile X syndrome
Nasser A. Elhawary, Imad A. AlJahdali, Iman S. Abumansour, et al.
Human Genomics (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 10
Variation of FMRP Expression in Peripheral Blood Mononuclear Cells from Individuals with Fragile X Syndrome
Jamie L. Randol, Kyoungmi Kim, Matthew D. Ponzini, et al.
Genes (2024) Vol. 15, Iss. 3, pp. 356-356
Open Access | Times Cited: 3
Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Idiopathic Autism Spectrum Disorder and Fragile X Syndrome: A Pilot Study
James Robert Brašić, Ayon Nandi, David Russell, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 2863-2863
Open Access | Times Cited: 21
Deletion of the Autism-Associated Protein SHANK3 Abolishes Structural Synaptic Plasticity after Brain Trauma
Carolina Urrutia‐Ruiz, Daniel Rombach, Silvia Cursano, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6081-6081
Open Access | Times Cited: 14
Effects of AFQ056 on language learning in fragile X syndrome
Elizabeth Berry‐Kravis, Leonard Abbeduto, Randi J. Hagerman, et al.
Journal of Clinical Investigation (2023) Vol. 134, Iss. 5
Open Access | Times Cited: 8
Sexually dimorphic patterns in electroencephalography power spectrum and autism-related behaviors in a rat model of fragile X syndrome
Hayes Wong, Alexander W.M. Hooper, Yosuke Niibori, et al.
Neurobiology of Disease (2020) Vol. 146, pp. 105118-105118
Open Access | Times Cited: 22
In vivo imaging of mGlu5 receptor expression in humans with Fragile X Syndrome towards development of a potential biomarker
Maria Mody, Yoann Petibon, Paul Kyu Han, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 18
A sensitive and reproducible qRT-PCR assay detects physiological relevant trace levels of FMR1 mRNA in individuals with Fragile X syndrome
Devan Straub, Lauren Schmitt, Anna E. Boggs, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
FMR1 Protein Expression Correlates with Intelligence Quotient in Both Peripheral Blood Mononuclear Cells and Fibroblasts from Individuals with an FMR1 Mutation
Poonnada Jiraanont, Marwa Zafarullah, Noor Sulaiman, et al.
Journal of Molecular Diagnostics (2024) Vol. 26, Iss. 6, pp. 498-509
Closed Access | Times Cited: 2
Profiling Genome-Wide DNA Methylation in Children with Autism Spectrum Disorder and in Children with Fragile X Syndrome
Mittal Jasoliya, Jianlei Gu, Reem Rafik AlOlaby, et al.
Genes (2022) Vol. 13, Iss. 10, pp. 1795-1795
Open Access | Times Cited: 11
Reduced Expression of Cerebral Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome
James Robert Brašić, Ayon Nandi, David Russell, et al.
Brain Sciences (2020) Vol. 10, Iss. 12, pp. 899-899
Open Access | Times Cited: 16
A Bibliometric Insight of Genetic Factors in ASD: Emerging Trends and New Developments
Kang Wang, Weicheng Duan, Yijie Duan, et al.
Brain Sciences (2020) Vol. 11, Iss. 1, pp. 33-33
Open Access | Times Cited: 15
Psychotropic Drug Treatment Patterns in Persons with Fragile X Syndrome
Kelli C. Dominick, Howard Andrews, Walter E. Kaufmann, et al.
Journal of Child and Adolescent Psychopharmacology (2021) Vol. 31, Iss. 10, pp. 659-669
Closed Access | Times Cited: 14
Heterogeneity in Fragile X Syndrome Highlights the Need for Precision Medicine-Based Treatments
Edgard Verdura, Laura Pérez‐Cano, Rubén Sabido-Vera, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top